Funds · NKTR

Who owns NKTR?

Institutional ownership of Nektar Therapeutics from Form 13F, Q2 2026

239 institutional managers reported holding Nektar Therapeutics (NKTR) in Form 13F filings for Q2 2026, with 35,923,530 shares worth $2.5B. The largest reported holder was FMR LLC. Managers that filed both quarters added a net 9,221,647 shares (+34.6%). 73 opened new positions and 41 sold out.

Funds holding
239
Value held
$2.5B
New / sold out
73 / 41
Net shares, same filers
+34.6%

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Largest holders of NKTR

FundValueShare of 13F holdingsSharesMove
FMR LLC$354M14.1%5,067,920Added
Two Seas Capital LP$216M8.6%3,092,234Added
BlackRock, Inc.$205M8.2%2,941,851Added
BVF Inc$167M6.7%2,391,075Trimmed
Vanguard Capital Management LLC$104M4.2%1,496,849Added
Two Sigma Investments, LP$83.9M3.3%1,202,004Added
Vestal Point Capital, LP$69.8M2.8%1,000,000Added
Morgan Stanley$65.4M2.6%936,560Added
State Street Corp$63.5M2.5%909,679Added
Geode Capital Management, LLC$61.5M2.5%881,306Added
Prosight Management, LP$56.5M2.3%810,000Added
Armistice Capital, LLC$50.5M2.0%724,000Added
Gilder Gagnon Howe & Co LLC$41.9M1.7%600,873Added
Millennium Management LLC$33.4M1.3%478,120Added
Braidwell LP$33.1M1.3%473,617Added
Sofinnova Investments, Inc.$32.9M1.3%471,763Trimmed
Woodline Partners LP$32.9M1.3%470,875Added
Orbimed Advisors LLC$32.5M1.3%465,346Added
UBS Group AG$29.9M1.2%428,400Added
Emerald Advisers, LLC$27.2M1.1%390,158Trimmed
Lord, Abbett & Co. LLC$26.6M1.1%381,624Trimmed
Vanguard Portfolio Management LLC$24.3M1.0%348,540Added
DAFNA Capital Management LLC$22.2M0.9%318,380Added
Northern Trust Corp$21.5M0.9%308,531Added
Deep Track Capital, LP$20.9M0.8%300,000New

Share of 13F holdings is each fund's shares as a share of the 35,923,530 NKTR shares all 13F filers reported, not of shares outstanding.

Biggest buyers in Q2 2026

  1. BlackRock, Inc. Added+$157M
  2. Two Seas Capital LP Added+$79.1M
  3. FMR LLC Added+$53.4M
  4. Vestal Point Capital, LP Added+$49.9M
  5. State Street Corp Added+$46.4M
  6. Geode Capital Management, LLC Added+$37.3M
  7. Gilder Gagnon Howe & Co LLC Added+$23.0M
  8. Deep Track Capital, LP New+$20.9M
  9. Vanguard Capital Management LLC Added+$20.9M
  10. Morgan Stanley Added+$19.3M

Biggest sellers in Q2 2026

  1. Invesco Ltd. Trimmed-$34.0M
  2. Citadel Advisors LLC Trimmed-$24.7M
  3. Qube Research & Technologies Ltd Trimmed-$18.2M
  4. JPMorgan Chase & Co Trimmed-$15.1M
  5. Patient Square Capital LP Sold out-$15.1M
  6. BVF Inc Trimmed-$11.8M
  7. Great Point Partners LLC Trimmed-$9.9M
  8. Marshall Wace, LLP Trimmed-$9.6M
  9. Squadron Capital Management LLC Sold out-$9.0M
  10. Jane Street Group, LLC Trimmed-$7.3M

The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $882M and sold $240M; 99 added and 40 trimmed.

Schedule 13D and 13G filings on NKTR

Owners of more than 5% must file within days, so these can be newer than the 13F data.

Questions about NKTR ownership

Who owns NKTR stock?
239 institutional investment managers reported NKTR positions in their Form 13F filings for Q2 2026, holding 35,923,530 shares worth $2.5B in total. FMR LLC reported the largest position.
Are funds buying or selling NKTR?
In Q2 2026, 73 managers opened new NKTR positions, 99 added, 40 trimmed and 41 sold out. Managers that filed in both quarters added a net 9,221,647 shares.
How current is this NKTR institutional ownership data?
It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to NKTR by CUSIP. Options are left out. NKTR news and filings · NKTR insider trades · Top funds